Loading...
First Round of Abstract Submission Ends: Dec 31, 2026
Extended Early Bird Ends: Oct 28, 2026

Keynote Speakers

Dr. Ru-song Zhao
Shandong University, China
Title: Applications of Endometrial Organoids in Reproductive Biology and Drug Screening
Rusong Zhao, PhD, is an associate professor and master's supervisor in the State Key Laboratory of Reproductive Medicine and Offspring Health at Nanjing Medical University. Her translational research bridges fundamental mechanistic discovery with unmet clinical needs in human reproductive health, focusing on post-implantation human embryogenesis, maternal–fetal crosstalk, endometrial receptivity and the modeling of human diseases. She received her PhD in obstetrics and gynecology from Shandong University in 2022.

Drawing on well-annotated clinical specimen cohorts, Dr. Zhao's laboratory integrates stem-cell engineering, spatial imaging and spatiotemporal multi-omics profiling to dissect the molecular and cellular origins of adverse pregnancy outcomes from both the maternal and fetal perspectives, while developing regenerative strategies for the embryo implantation niche using human endometrial organoids, stem-cell platforms, natural bioactive agents and functional biomaterials. Her current areas of research include: 1) the construction, regeneration and translational validation of human endometrial organoids in disease modeling; 2) maternal–fetal interaction and the mechanisms of recurrent implantation failure; 3) embryonic organogenesis in pathological pregnancy and the mechanisms and interventional modulation of human oocyte in vitro maturation.

As first or corresponding author, Dr. Zhao has published 11 peer-reviewed articles in leading international journals, including Cell Stem Cell, Nature Cell Biology, eLife, Science China Life Sciences and Cell Proliferation, and holds five granted Chinese invention patents. Her research is supported by the National Natural Science Foundation of China, the National Key Research and Development Program of China, the National Postdoctoral Program of China and a Key Laboratory of the National Health Commission. She also serves as a Youth Committee Member of the Specialized Committee for Stem Cell Technology and Clinical Application Research, Shandong Medical Association.
Prof. Mizrahi Reuveni Miri
Reichman University, Israel
Title: Her Physiological Age: A New Lens on Women’s Health and Longevity
Will update soon.
Prof. Bo Jacobsson
University of Gothenburg, Sweden
Title: To be confirmed.
Professor Bo Jacobsson is an internationally recognized leader in maternal and newborn health and a leading expert on preterm birth, with expertise in its epidemiology, underlying biological mechanisms, genetics, and prevention. He is Chair of Obstetrics and Gynecology at the Sahlgrenska Academy, University of Gothenburg, and Sahlgrenska University Hospital, one of the largest university hospitals in Northern Europe, with approximately 10,000 deliveries annually.

A central theme of Professor Jacobsson’s research is understanding why preterm birth occurs and what determines variation in preterm birth rates at both the population and individual levels. His work encompasses the epidemiological and population-level factors that influence the overall rate of preterm birth, including how changes in maternal characteristics, clinical practices, environmental exposures, and broader societal factors may affect rates over time and across populations. This population perspective is closely integrated with his longstanding interest in understanding the biological mechanisms that initiate and regulate parturition and lead to preterm birth. By combining epidemiology with mechanistic and molecular research, his work seeks to understand both the determinants of preterm birth at the population level and the biological pathways responsible for its occurrence in individual pregnancies.

Within this broader research program, Professor Jacobsson and his research group have been at the forefront of the genetics of gestational duration and preterm birth. Their work aims to identify the genetic and biological factors that determine the timing of birth and to understand how these factors interact with maternal, fetal, environmental, and clinical influences. A central objective is to translate insights from genetics, epidemiology, and biological mechanisms into improved prediction and, ultimately, effective strategies for preventing preterm birth and improving outcomes for babies born preterm.

Professor Jacobsson has made substantial contributions to the scientific understanding of pregnancy, parturition, and preterm birth. He has authored or co-authored more than 430 scientific publications, including articles in some of the world’s most prestigious scientific and medical journals, such as Nature, Science, The New England Journal of Medicine, Nature Genetics, PLOS Medicine, and JAMA. His work has achieved an H-index 94 according (Google Scholar), reflecting the broad impact and international recognition of his research.

Alongside his academic and clinical leadership, Professor Jacobsson has been actively engaged in international efforts to advance maternal, newborn, and child health for more than two decades. He has contributed his expertise to several World Health Organization (WHO) initiatives and special task groups and served as co-leader of the Maternal, Newborn and Child Health (MNCH) working group within the Partnership for Maternal, Newborn & Child Health.

Professor Jacobsson has also played a prominent role in shaping the international agenda on preterm birth. He served as co-editor of the WHO report Born Too Soon: Decade of Action on Preterm Birth and as co-chair of the Global Advocacy Group. From 2021 to 2025, he was the inaugural Director of the Division of Maternal and Newborn Health at the International Federation of Gynecology and Obstetrics (FIGO).”